Identification of a Novel Drug Sensitivity Biomarker Neuregulin-2 for Venetoclax in Non-t(11;14) Multiple Myeloma

Yujun Dai,Xue-Ping Li,Fang Hu,Jinyuan Li,Yang Liang, Da-Wei Wang,Zhongjun Xia,Xiaoqin Chen

Blood（2021）

引用 2|浏览7

暂无评分

摘要

Multiple myeloma (MM) is a malignant hematological cancer of plasma cells origin. However, MM with/without t(11;14) exists a huge therapeutic venetoclax response gap.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要